Objective-Flow (shear stress)-mediated outward remodeling (FMR) of resistance arteries is a key adaptive process allowing collateral growth after arterial occlusion but declining with age. 17-β-estradiol (E2) has a key role in this process through activation of estrogen receptor α (ERα). Thus, we investigated the impact of age and timing for estrogen efficacy on FMR. Approach and Results-Female rats, 3 to 18 months old, were submitted to surgery to increase blood flow locally in 1 mesenteric artery in vivo. High-flow and normal-flow arteries were collected 2 weeks later for in vitro analysis. Diameter increased by 27% in high-flow arteries compared with normal-flow arteries in 3-month-old rats. The amplitude of remodeling declined with age (12% in 18-month-old rats) in parallel with E2 blood level and E2 substitution failed restoring remodeling in 18-month-old rats. Ovariectomy of 3-, 9-, and 12-month-old rats abolished FMR, which was restored by immediate E2 replacement. Nevertheless, this effect of E2 was absent 9 months after ovariectomy. In this latter group, ERα and endothelial nitric oxide synthase expression were reduced by half compared with age-matched rats recently ovariectomized. FMR did not occur in ERα −/− mice, whereas it was decreased by 50% in ERα +/− mice, emphasizing the importance of gene dosage in high-flow remodeling. Conclusions-E2 deprivation, rather than age, leads to decline in FMR, which can be prevented by early exogenous E2.
T he nitric oxide (NO) pathway has an important protective role in heart and blood vessels, and shear stress attributable to blood flow is a potent endogenous stimulus for endothelial NO synthase (eNOS) expression level. 1, 2 A decreased NO production by endothelial cells is associated with higher risk of cardiovascular diseases, 3 and a reduced responsiveness to flow (flow-mediated dilation) is the hallmark of endothelium dysfunction. 4, 5 Chronic increases in blood flow induce outward hypertrophic remodeling in resistance arteries associated with improved NO-dependent dilation. 6, 7 This remodeling occurs in physiological situations, such as growth, pregnancy, or exercising, and has a key role in postischemic revascularization because it allows collateral arteries growth and arteriogenesis. 8 Nevertheless, the ability of resistance arteries to remodel in response to a chronic increase in blood flow is reduced in rat models of aging, 9, 10 hypertension, 11 and diabetes mellitus. 12, 13 It should be noted that these studies were performed in male rats only, and that we recently demonstrated an important role of female sex hormones in the mechanism of flow-mediated remodeling (FMR). Indeed, FMR is absent in ovariectomized female rats and in mice lacking the estrogen receptor α (ERα). 14 Epidemiological studies have demonstrated that women, before menopause, are better protected than men against cardiovascular diseases. 15 Indeed, vascular and heart cells contain specific high-affinity receptors for estrogen in both humans 16 and animals. 17 Furthermore, estrogens stimulate eNOS leading to NO production. Both animal and human studies have shown that the decline in ovarian function is associated with decreased NO production. 18, 19 Stimulation of the NO-pathway may explain, at least in part, the protective effect of estrogens on the vascular wall. 20, 21 However, some aspects of vascular protection, such as atheroprotection, are not dependent on NO, showing that multiple mechanisms concur to estrogen-dependent protection, 22 although endothelial ERα again plays a prominent role. 23 Nevertheless, a controversy remains regarding the beneficial effect of estrogen treatment after menopause. This beneficial effect has been questioned after 2 interventional studies, the Heart and Estrogen/ Progestin Replacement Study (HERS) and the Women's Health Initiative (WHI). 15 The initial results suggested a negative impact of the treatment, leading to a worldwide reduction in the use of substitution therapies. Nevertheless, recent publications with a more detailed analysis of the data countermanded the initial conclusion. Interestingly, a major difference in the effect of hormones between younger and older women has been shown. Indeed, the treatment tended to confer coronary protection in women treated within 10 years after menopause, whereas a latter treatment may induce deleterious effects. 24 The mechanisms accounting for the impact of timing in the atheroprotective action of estrogens has been recently reviewed. 15 In particular, it has been described, in the atheroma plaque, a decreased ERα expression 16, 25 and an increase in 27-hydroxycholesterol (27HC) production. 26 Indeed, 27HC is a competitive antagonist of ER action, which can counteract the protective action of 17-β-estradiol (E2). 26 To better understand to which extent a timing effect also can impact the function of arterioles, we investigated FMR of resistance arteries in young and old female rats and then in young ovariectomized rats as a model of surgical menopause.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Estradiol Blood Level and FMR
Fourteen days after arterial ligation, arterial diameter was determined in vitro in response to stepwise increases in intraluminal pressure. Passive arterial diameter was significantly higher in high-flow (HF) than in normal-flow (NF) arteries in 3-month-old female rats ( Figure 1A ). The percentage of increase in diameter in HF arteries declined progressively with age in 3-to 18-month old female rats ( Figure 1B ). Interestingly, E2 blood level also decreased progressively with age ( Figure 1C ), although these endogenous levels were sufficient to maintain a normal uterus weight, with the exception of a slight decline in 18-month-old rats ( Figure 1D ).
In 18-month-old female rats treated for 3 weeks with exogenous E2, E2 blood level met those levels measured in young rats (24±4 pg/mL in E2-treated 18-month-old rats versus 20±4 pg/mL in 3-month-old rats and 4±1 pg/mL in 18-month-old rats without treatment). Nevertheless, remodeling did not differ between treated and untreated rats ( Figure 1E ) despite a significant effect of E2 on uterus weight (660±83 mg with treatment versus 426±69 mg without treatment).
Endogenous Estradiol and FMR
E2 blood level and uterus weight were significantly reduced in ovariectomized rats compared with that in control and E2-treated ovariectomized rats, whereas mean arterial pressure and body weight were not affected by the ovariectomy or by the treatment with E2 (Table) . FMR in 3-month-old female rats did not occur in ovariectomized rats ( Figure I Figure 1 . Arterial diameter measured in response to stepwise increases in pressure in mesenteric arteries submitted chronically to high flow (HF) or to normal flow (NF). Arteries were isolated from 3-and 18-month-old female rats (A and B). To facilitate intergroup comparison, the increase in diameter attributable to the chronic increase in blood flow was expressed as percentage increase in diameter (HF−NF / NF×100, B). Estradiol (E2) blood level (C) and uterus weight (D) were measured in these rats. Arterial diameter was also measured in HF and NF arteries isolated from 18-month-old intact female rats treated or not with E2 (E). Mean±SEM is represented (n=12 rats per group). *P<0.05, HF vs NF. #P<0.05 vs 3-or 6-month-old rats.
online-only Data Supplement). In ovariectomized rats treated with E2, remodeling was equivalent to control, confirming that E2 is involved in remodeling.
Prolonged Ovariectomy and FMR
In 6-month-old rats, ovariectomy prevented HF remodeling (ie, diameter under 100 mm Hg was 388±18 versus 375±21 μm in intact rats, n=8 per groups), whereas after ovariectomy followed by immediate treated with E2, HF remodeling was equivalent to that in intact rats ( Figure II in the online-only Data Supplement). In 6-month-old rats ovariectomized at 3 months (Figure IIC and IID in the online-only Data Supplement), FMR did not occur but exogenous E2 restored in part remodeling (10±3% versus 22±4% increase in diameter in HF versus NF arteries, P<0.001).
In 12-month-old rats, intact or ovariectomized and immediately treated with E2, FMR was significant (Figure 2A and 2B). No remodeling occurred in rats ovariectomized at 12 months (ie, diameter <100 mm Hg was 406±20 versus 394±19 μm in intact rats, n=8 per groups).
In 12-month-old rats ovariectomized at 3 months, FMR did not occur ( Figure 2C ), and a treatment with E2 was inefficient ( Figure 2D ).
E2 blood level and uterus weight were significantly reduced in ovariectomized rats at 3 months and in rats ovariectomized at 6 or 12 months. In all groups, the treatment with E2 increased uterus weight to control level (Table) .
Prolonged Ovariectomy and Compensatory Increase in Arterial Wall Mass
In 12-month-old rats, intact or ovariectomized+E2, cross-section area ( Figure 3A ) and media thickness ( Figure 3B ) were higher in HF than in NF arteries. In rats ovariectomized for 9 months, treated or not with E2,
Table. Body Weight, Mean Arterial Pressure, and Uterus Weight Measured in 3-to 12-Month-Old Female Rats and Submitted to 3-Week, 3-Month, or 9-Month Ovariectomy
Rats were treated or not with 17-β-estradiol (E2) for 2 weeks or not. Mean±SEM is shown (n=12 rats per group). OVX indicates ovariectomized. *P<0.05 vs control.
cross-sectional area and media thickness in HF arteries were not significantly higher compared with NF arteries ( Figure 3A and 3B). Wall-to-lumen ratio was similar in HF and NF arteries in all 4 groups ( Figure 3C ); nevertheless, it was significantly greater in rats ovariectomized for 9 months (with or without E2) compared with the 2 other groups.
Endothelium (NO)-Mediated Relaxation
In rats ovariectomized at 12 months, a treatment with E2 improved acetylcholine-mediated dilation significantly, whereas in rats ovariectomized at 3 months, E2 did not change acetylcholine-mediated dilation ( Figure 4A ). Acetylcholine-mediated relaxation was fully dependent on the production of NO because N(omega)-nitro-l-arginine Figure 3 . Media cross-section area (CSA; A), media thickness (B), and wall-to-lumen ratio (C) obtained in mesenteric arteries submitted chronically to high flow (HF) or to normal flow (NF). Arteries were isolated from 12-month-old intact rats (12 months), 12-month-old rats ovariectomized (12-month OVX) at 12 months and treated with 17-β-estradiol (E2; OVX+E2 at 12 months), 12-month-old rats ovariectomized at 3 months and left untreated (9-month OVX/), and 12-month-old rats ovariectomized at 3 months and treated with E2 at 12 months (9-month OVX+E2 Figure 2 . Arterial diameter measured in response to stepwise increases in pressure in mesenteric arteries submitted chronically to high flow (HF) or to normal flow (NF). Arteries were isolated from 12-month-old female rats. Rats were intact rats (A), rats ovariectomized (OVX) at 12 months (B) and treated with 17-β-estradiol (E2), rats ovariectomized at 3 months (C) and rats ovariectomized at 3 months and treated with E2 at 12 months. Mean±SEM is represented (n=12 rats per group). *P<0.05, HF vs NF arteries.
methyl ester suppressed relaxation in all groups ( Figure 4B ). Endothelium-independent relaxation induced by sodium nitroprusside was significantly higher in rats ovariectomized at 3 months compared with rats ovariectomized at 12 months, irrespective of the treatment with E2 ( Figure 4C ).
ERα and eNOS Expression Level
In 12-month-old rats ovariectomized at 12 months and treated with E2 and in intact 12-month-old rats, ERα and eNOS expression level was higher than that in 12-month-old rats ovariectomized at 3 months, treated or not with E2 ( Figure 5A ). Moreover, in 12-month-old rats ovariectomized at 12 months and treated with E2 and in intact 12-month-old rats, ERα and eNOS expression level was higher in HF than in NF vessels as evidenced by a ratio of HF to NF ranging from 1.3 to 1.8 ( Figure 5B ). This was not observed in 12-month-old rats ovariectomized at 3 months, treated or not with E2 ( Figure 5B ). The ratio of phosphorylated eNOS to eNOS was similar in the 4 study groups ( Figure III in the online-only Data Supplement).
Extracellular Signal-Regulated Kinase 1/2, Nicotinamide Adenine Dinucleotide Phosphate-Oxidase, and Superoxide Dismutase
Extracellular signal-regulated kinase 1/2 (ERK1/2) expression level tended to be higher in 12-month-old rats ovariectomized for 9 months whether they were treated with E2 or not. The ratio of phosphorylated ERK1/2 to ERK1/2 was similar in the 4 study groups ( Figure IV in the online-only Data Supplement). Nevertheless, the ratio of ERK1/2 in HF vessels to ERK1/2 in NF arteries was significantly lower in rats submitted to prolonged (9 months) ovariectomy ( Figure  IV in the online-only Data Supplement).
Akt expression level and the ratio of phosphorylated Akt were not significantly affected by the different protocols ( Figure V in the online-only Data Supplement). Extracellular superoxide dismutase (EcSOD) and manganese superoxide dismutase (MnSOD) expression levels were not significantly affected by the ovariectomy or the treatment with E2 in the different study groups ( Figure VI in the online-only Data Supplement). The ratio of EcSOD in HF vessels to EcSOD in NF arteries was significantly lower in rats submitted to 9 months of ovariectomy ( Figure IV in the online-only Data Supplement). This was not observed with MnSOD.
P67phox ( Figure VII in the online-only Data Supplement), p22phox, and gp91phox ( Figure VIII in the online-only Data Supplement) expression levels were significantly lower in 12-month-old rats ovariectomized for 9 months whether they were treated with E2 or not. Nevertheless, the ratio of the expression levels measured in HF vessels to that measured in NF arteries was not significantly different among the 4 study groups.
Inflammatory Response
Tumor necrosis factor α, COX-2 (cyclooxygenase-2), and HO-1 (heme-oxigenase-1) expression levels were not significantly affected by ovariectomy with or without E2-treatment ( Figure IX in the online-only Data Supplement).
FMR in ERα Knockout Mice
Diameter expansion occurred in wild-type ( Figure 6A ) and ERα +/− mice ( Figure 6B ) and not in ERα −/− mice ( Figure 6C ). However, the amplitude of remodeling ( Figure 6D ) in ERα +/− mice was half that observed in ERα +/+ mice.
Discussion
The main finding of the present study is that estrogens prevent the decline in FMR occurring with age, and that deprivation of E2, rather than age, leads to a rapid decline in FMR. A gap of 9 months between endogenous estrogen deprivation and exogenous E2 substitution impairs E2 action, underlining the importance of timing of E2 effect on this vascular process. A 2-fold decrease in both ERα and eNOS expression levels, associated with reduced NO-dependent relaxation, could play a key role in this process.
A chronic increase in blood flow induces changes in structure and function of arterioles or resistance arteries with an increase in diameter and wall mass (hypertrophy) and improved Figure 4 . Concentration-response curve to acetylcholine (A) performed in the thoracic aorta isolated from 12-month-old rats ovariectomized at 12 months (OVX) and treated or not with 17-β-estradiol (E2) at 12 months. Rats were also 12-monthold rats ovariectomized at 3 months (9-month OVX), treated or not with E2 at 12 months. Concentration response curve to acetylcholine was repeated in the presence of the nitric oxide synthase blocker N(omega)-nitro-l-arginine methyl ester (B). Endothelium-independent relaxation induced by sodium nitroprusside (SNP) is shown in (C). The insets show the precontraction applied to arteries before addition of acetylcholine (A) or SNP (C). Mean±SEM is represented (n=12 rats per group). *P<0.05, OVX vs OVX+E2. #P<0.05, rats with prolonged (9 months) ovariectomy vs rats with ovariectomy at 12 months.
endothelium-dependent dilation. 6, 10, 12, [27] [28] [29] This remodeling has a major role in growth, pregnancy, and exercising as well as in ischemic diseases. Indeed, it is important for collateral arteries growth after occlusion of a larger artery, and consequently it is essential for postischemic revascularization. 30 FMR is strongly reduced in physiological aging as evidenced in male rats 12 9 to 24 months old. 10 It is also reduced or absent in diseases associated with disturbed local blood flow supply, such as obesity, 27 diabetes mellitus, 12, 13 and hypertension. 11 Nevertheless, these studies have been performed in young male rats, and limited information is available in female rats. In humans, the probability to face cardiovascular events increases after 40 years, 31 especially in men, because women are better protected than men before menopause. 15 In agreement with these observations, we found that remodeling was maintained in 3to 18-month old female rats, although its amplitude decreased progressively to reach 10% in 18-month-old rats versus 30% in 3-to 6-month-old rats. This was correlated with a progressive decline in circulating E2 level. Nevertheless, treating 18-monthold female rats with E2 did not increase the amplitude of remodeling, suggesting that irreversible changes occurred.
To better understand this latter observation, remodeling was then investigated in young female rats submitted to prolonged estrogen deprivation to mimic menopause experimentally without interaction with the effect of aging. We evidenced a nonreversible loss of the capacity of E2 to improve remodeling after prolonged estrogen deprivation. This finding is important with regard to the controversy existing on the beneficial effect of estrogen treatment after menopause. 15 Indeed, despite the results of the initial trials 32,33 that brought out the controversy, more recent works show that estrogen substitution therapy is efficient in women treated within the decade after menopause. 24, 34 Furthermore, the present study is also of interest for the management and treatment of women with primary ovarian insufficiency. 35, 36 Whereas E2 lost its efficacy on FMR after prolonged ovariectomy, HF arteries are able to develop hypertrophy so that the wall-to-lumen ratio was excessively high. This has been associated with the occurrence of vascular disorders, 37 strengthening the importance of E2 and timing in the protection of the vascular wall.
We have previously shown that E2 and ERα are important for the last phase of FMR, with activation of the expression of eNOS needed for the diameter expansion. 14 The findings of the present study are in agreement with our previous observation with no obvious effect of E2 on inflammation and oxidative stress. Nevertheless, FMR of resistance arteries depends on eNOS expression level and NO production 7, 38 under the influence of ERα. 14 The expression level of eNOS and ERα and their activity are modulated by E2. 39 Moreover, the disruptive mutation in the estrogen receptor gene described in 1 man 40 is associated with absence of flow-mediated dilation of the brachial artery, 41 and flow-mediated dilatation is reduced in men treated with aromatase inhibitors. 42 These studies suggest that the acute endothelial response to flow (shear stress) depends on ERα activation. Furthermore, in premenopausal women, endothelial ERα expression level is modulated by estrogens and correlated to eNOS expression and NO-dependent dilation of the brachial artery; ERα and eNOS expression levels as well as flow-dependent dilation being reduced in menopaused women. 43 In agreement with this study, we found that ERα and eNOS expression levels are higher in intact 12-month-old rats than in ovariectomized age-matched rats. Nevertheless, a main finding of the present study is that E2 failed to increase eNOS and ERα expression after 9 months of estrogen deprivation. Consequently, E2 failed improving endotheliumdependent dilation. In all groups, endothelium-dependent dilation was totally suppressed by N(omega)-nitro-l-arginine methyl ester showing that it was fully dependent on NO synthesis. Our observation is in agreement with a previous study showing that prolonged ovariectomy (≤18 months) in the rat induces a reduction in NO-dependent relaxation in the tail artery. 44 Furthermore, the present study provides a possible explanation for the observations made in estrogen treatment in monkeys started shortly after the establishment of estrogen deficiency prevents atherosclerosis whereas this protective effect is lost when the treatment is delayed. 45 Because the loss of function in rats submitted to a 9-month estrogen deprivation was associated with a 50% reduction in ERα expression level, we submitted ERα −/+ mice to a chronic increase in blood flow in vivo and found that this was associated with a 50% reduction in remodeling. This result shows that FMR is sensitive to ERα gene dosage.
Finally, in rats submitted to prolonged ovariectomy, treated or not with E2, endothelium-independent relaxation induced by the NO donor sodium nitroprusside was higher than in intact rat, suggesting an improved sensitivity to NO of the vascular smooth muscle cells, most probably to compensate for the reduced production of NO by the endothelium as evidenced by a diminished acetylcholine-dependent relaxation. This in agreement with previous studies showing that the chronic treatment with the NO synthesis blocker N(omega)-nitro-l-arginine methyl ester was associated with increased sensitivity of the uterine artery, 46 in the aorta, 47 and in the mesenteric resistance artery. 48
Pathophysiological Consideration
Our study brings new insights into the role of estrogens on long-term vascular homeostasis. Besides confirming the key role of E2 and ERα in FMR of resistance arteries, we demonstrated experimentally the correlation between E2 blood level and the amplitude of the remodeling in response to a chronic increase in blood flow. This remodeling has a key role in postischemic revascularization, and our finding could provide an explanation, at least in part, for the protective effect of estradiol in women aged >65 years.
Interestingly, we also found that a prolonged estrogen deprivation induced a loss of the ability of the arteries to adapt in response to a chronic increase in blood flow, thus bringing a new insight in our understanding of the timing effect. Indeed, the downregulation of ERα could be a crucial event of the timing effect that should be taken into account to better understand the lack of protection of hormonal substitutive treatment described in the HERS and in the WHI study. 32, 33 
Conclusion
Our study showed that aging in female rats was associated with a progressive reduction in both FMR and blood E2. Prolonged estrogen deprivation induced a loss of the ability of E2 to restore remodeling in association with reduced ERα and eNOS expression level, providing a possible explanation for the timing effect in the failure of delayed estrogens to confer vascular protection.
